On Jan. 11, 2021, TheNew York Times posted an article about the virtues of fecal immunochemical testing relative to colonoscopy. The story, “A Colonoscopy Alternative Comes Home” [https://www.nytimes.com/ 2021/ 01/ 11/ health/ colonoscopy-health-home-testing.html] depicted colonoscopy as a comparatively risky procedure with few advantages over less invasive methods of testing for colorectal cancer. It also offered the speculation that financial factors— namely, greater reimbursement for endoscopy—was behind the general preference of gastroenterologists for colonoscopy over stool tests.
Trending
- Meet the gastroenterologists of the 10 top hospitals for GI (Becker’s GI & Endoscopy)
- Acute gastroenteritis linked to increased odds for postinfection IBS, functional dyspepsia (Healio)
- Private equity-backed providers represent less than 4% of US market: PitchBook (Healthcare Dive)
- In Memoriam: Ikuo Hirano, MD, AGAF (AGA)
- Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening (Business Wire)
- Video: Early Detection and Innovative Solutions for Colorectal Cancer with Michael Sapienza (Target Cancer | Youtube)
- Risk Stratification May Work Well for FIT-Based CRC Screening in Elderly (MDedge)
- AI In Medicine: 3 Future Scenarios From Utopia To Dystopia (The Medical Futurist)